TITLE

Cryptococcosis in the Developing World: An Elephant in the Parlor

AUTHOR(S)
Pappas, Peter G.
PUB. DATE
February 2010
SOURCE
Clinical Infectious Diseases;2/1/2010, Vol. 50 Issue 3, p345
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article the author discusses the overwhelming numbers of the cases of central nervous system cryptococcosis in sub-Saharan Africa. The author states that the failure of health care provision has been attributed to little access to effective antifungal therapy, few clinical initiatives, culture, and economy. Moreover, the author outlines the findings of prospective studies about the treatment regimens of cryptococcal meningitis in patients infected with human immunodeficiency virus (HIV).
ACCESSION #
47615075

 

Related Articles

  • treatment-naïve:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p216 

    A definition of the term "treatment-naïve" is presented. It refers to patients who have no history of having been treated for a specific condition with a particular drug. HIV-positive persons who have not been subjected to monotherapy have the best chance of driving their viral load to...

  • superinfection a changing picture. Duffin, Ross // HIV Australia;Jun-Aug2004, Vol. 3 Issue 4, p9 

    Discusses the impact of superinfection on an individual's HIV disease progression. Overview of several HIV superinfection cases in Australia; Frequency of the occurrence of superinfection; Recommended approach to prevent HIV superinfection.

  • Chapter #4: Controlling HIV and AIDS. Gedatus, Gustav Mark // HIV & AIDS (0-7368-0281-9);2000, p28 

    The chapter focuses on the importance of knowing one's HIV status to control its effects and to protect others from the virus. Testing for HIV can be done confidentially or anonymously for complete privacy. HIV-positive people need to eat right, exercise, get plenty of rest, and avoid tobacco,...

  • Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Elford, J.; Ibrahim, F.; Bukutu, C.; Anderson, J. // Sexually Transmitted Infections;Jun2008, Vol. 84 Issue 3, p176 

    Objective: To examine, by ethnicity, gender and sexual orientation, uptake of antiretroviral treatment among people living with HIV in London. Methods: Between June 2004 and June 2005, 1687 people living with HIV (73% response) receiving treatment and care in North East London National Health...

  • Elvitegravir non-inferior to raltegravir in treatment-experienced patients.  // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p12 

    The article focuses on a study which compared the effectiveness of once-daily elvitegravir and twice-daily raltegravir in treating HIV-1 infected patients.

  • Evaluation of a Newly Developed Lateral Flow Immunoassay for the Diagnosis of Cryptococcosis. Lindsley, Mark D.; Mekha, Nanthawan; Baggett, Henry C.; Surinthong, Yupha; Autthateinchai, Rinrapas; Sawatwong, Pongpun; Harris, Julie R.; Park, Benjamin J.; Chiller, Tom; Balajee, S. Arunmozhi; Poonwan, Natteewan // Clinical Infectious Diseases;8/15/2011, Vol. 53 Issue 4, p321 

    Background. Cryptococcosis is a common opportunistic infection of human immunodeficiency virus (HIV)- infected individuals mostly occurring in resource-limited countries. This study compares the performance of a recently developed lateral flow immunoassay (LFA) to blood culture and enzyme...

  • A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV-Associated Cryptococcal Meningitis. Pappas, Peter G.; Chetchotisakd, Ploenchan; Larsen, Robert A.; Manosuthi, Weerawat; Morris, Michele I.; Anekthananon, Thomansak; Sungkanuparph, Somnuek; Supparatpinyo, Khauncahi; Nolen, Tracy L.; Zimmer, Louise O.; Kendrick, Amy S.; Johnson, Phillip; Sobel, Jack D.; Filler, Scott G. // Clinical Infectious Diseases;6/15/2009, Vol. 48 Issue 12, p1775 

    Background. Cryptococcosis is a life-threatening infection among patients with human immunodeficientcy virus (HIV) infection. Therapeutic options for the treatment of central nervous system cryptococcosis are limited, especially in resource-limited settings. Methods. We conducted a randomized,...

  • Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia. Beyene, Tafese; Woldeamanuel, Yimtubezinash; Asrat, Daniel; Ayana, Gonfa; Boulware, David R. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: Cryptococcal meningitis is a major cause of HIV/AIDS-related deaths in Africa. Cryptococcosis is a neglected killer. However, meningitis can be prevented by early cryptococcal antigen (CrAg) screening and preemptive antifungal treatment during a prolonged period of detectable,...

  • Study finds intensive coaching improves antiretroviral therapy adherence.  // American Journal of Health-System Pharmacy;9/1/2002, Vol. 59 Issue 17, p1600 

    The article examines a study by researchers at the University of Buffalo (UB) that found a sharp decrease in viral load among newly diagnosed HIV-positive patients who received intensive medication-adherence coaching from pharmacists in the first 16 weeks of therapy. The study showed that an...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics